Spinal muscular atrophies

Spinal muscular atrophies (SMA) are a group of neuromuscular disorders that result in the loss of motor neurons and progressive muscle wasting. The severity of symptoms and age of onset varies by the type. Some types are apparent at or before birth while others are not apparent until adulthood. The different types of SMA are caused by changes in the same group of genes, and can affect both children and adults.

Types of Spinal Muscular Atrophies

There are several types of spinal muscular atrophies, which are classified based on the age of onset and the severity of symptoms. These include:

• SMA Type I: Also known as Werdnig-Hoffmann disease, this is the most severe type of SMA and is usually apparent at birth.
• SMA Type II: This type of SMA is less severe than type I, but still causes significant disability. Symptoms usually begin in infancy or early childhood.
• SMA Type III: Also known as Kugelberg-Welander disease, this type of SMA has a later onset and a slower progression than the other types. Symptoms usually begin in late childhood or early adolescence.
• SMA Type IV: This is the least severe type of SMA, with symptoms usually not appearing until adulthood.

Causes

Spinal muscular atrophies are caused by mutations in the SMN1 gene. This gene is responsible for the production of a protein that is critical for the function of nerves that control our muscles. Without it, those nerve cells cannot properly function and eventually die, leading to debilitating and often fatal muscle weakness.

Treatment

There is currently no cure for spinal muscular atrophies, but treatment can help manage symptoms and improve quality of life. Treatment options include physical therapy, occupational therapy, and various types of supportive care. In some cases, medications may be used to manage symptoms or slow the progression of the disease.

Research

Research into spinal muscular atrophies is ongoing, with scientists working to better understand the disease and develop new treatments. This includes research into gene therapy, which holds promise for the future treatment of SMA.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian